Renaissance Capital logo

AHPAU News

Healthcare SPAC Avista Public Acquisition II prices $200 million IPO

AHPAU

Avista Public Acquisition II, a blank check company formed by Avista Capital Partners targeting the healthcare sector, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company is led by Executive Chairman Thompson Dean and ...read more

Healthcare-focused SPAC Avista Public Acquisition II files for a $200 million IPO

AHPAU

Avista Public Acquisition II, a blank check company formed by Avista Capital Partners targeting the healthcare sector, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The New York, NY-based company plans to raise $200 million by offering 20 million units at $10 per unit. Each unit contains one share of common stock and one-third of a...read more

US IPO Weekly Recap: First oil & gas producer in two years pops; other 3 IPOs break

XOG

Four IPOs raised $816 million this week, led by Extraction Oil & Gas. The company broke a 2-year drought in IPOs from energy E&Ps and popped 15%, while the week's other three IPOs broke issue. Two had double-digit drops, the year's worst debuts outside the biotech sector. The last time one week had three IPOs end their first day negative was October 2015. With 10 IPOs...read more

Blank check company Avista Healthcare Public Acquisition prices $300 million IPO at $10

Avista Healthcare Public Acquisition, a blank check company formed by Avista to acquire a health care company, raised $300 million by offering 30 million shares at $10, as expected. Avista was behind 2014 IPO INC Research (INCR) and 2015 IPO Lantheus (LNTH). The SPAC plans to list on the Nasdaq under the symbol AHPAU. Credit Suisse acted as a lead manager on the deal....read more